Vitality Watch

Dossier pubmed observational 16-sep-2026
Human cohort, case-control, or epidemiological association

Retrotransposable element derepression distinguishes DNMT3A-mutant from TET2-mutant clonal haematopoiesis.

Key claim: High-VAF DNMT3A-mutant clonal haematopoiesis shows widespread retrotransposable-element derepression linked to TNF-α/NF-κB, interferon, and senescence inflammatory signatures, while TET2-mutant clones lack RTE-driven inflammation and instead enrich oxidative phosphorylation, ROS, and mTORC1 pathways.

Abstract

Clonal haematopoiesis (CH) is driven by somatic mutations in haematopoietic stem cells that generate clonal populations detectable in peripheral blood and is present in 10-20% of individuals over the age of 65. Mutations in DNMT3A and TET2 are the most common drivers and have been linked to inflammatory phenotypes and increased risk of haematologic and cardiovascular disease. However, the cell-intrinsic mechanisms connecting these mutations to inflammatory signalling remain incompletely understood. Because retrotransposable elements (RTEs) are epigenetically regulated and can activate innate immune pathways when derepressed, we hypothesised that RTE reactivation may represent a mutation-specific mechanism linking clonal haematopoiesis driver mutations to inflammatory pathways. We analysed RTE expression and clonal burden in peripheral blood mononuclear cell (PBMC) samples from 56 individuals with CH and 12 non-CH controls using integrated genomic and transcriptomic approaches, with complementary validation by TARGET-seq across haematopoietic lineages. High variant allele frequency (VAF; > 10%) DNMT3A-mutant clones exhibited widespread derepression of RTEs, particularly LINE and LTR families, whereas TET2-mutant clones showed a trend towards reduced RTE expression relative to controls. Transcriptomic analyses revealed that DNMT3A high-variant allele frequency clones with elevated RTE expression were enriched for inflammatory signalling pathways, including TNF-α/NF-κB signalling, interferon responses, and senescence-associated signatures. In contrast, TET2-mutant clones lacked these RTE-associated inflammatory signatures and instead showed enrichment of oxidative phosphorylation, reactive oxygen species signalling, and a mechanistic target of rapamycin complex 1 pathway. These findings were reproduced in an independent cohort. Collectively, our results highlight mutation-specific inflammatory mechanisms in clonal haematopoiesis and provide a foundation for future functional and preclinical studies to determine whether modulation of RTE activity can influence the inflammatory phenotype of DNMT3A-mutant CH and represent a potential therapeutic strategy.

Why this matters

Clonal hematopoiesis is treated as a monolithic aging risk state, but this human profiling shows the two dominant driver mutations follow different mechanistic routes: DNMT3A loss opens heterochromatin over LINE/LTR elements and lights up TNF-α/NF-κB, interferon, and senescence programs, while TET2 loss instead reshapes OXPHOS, ROS, and mTORC1 tone. That split matters for how CHIP is expected to feed inflammaging, for which subsets are candidates for anti-inflammatory versus metabolic geroprotectors, and for whether RTE-directed interventions (reverse-transcriptase inhibitors, STING modulation) would apply broadly or only to the DNMT3A arm.

Source

Link

Briefing card

Retrotransposable element derepression distinguishes DNMT3A-mutant from TET2-mutant clonal haematopoiesis.
Stage: observational · pubmed · 16-sep-2026

If you carry a DNMT3A CHIP mutation, this study links it to retrotransposon-driven inflammation, a different biology than TET2 CHIP, which instead shifts metabolic pathways.

High-VAF DNMT3A-mutant clonal haematopoiesis shows widespread retrotransposable-element derepression linked to TNF-α/NF-κB, interferon, and senescence inflammatory signatures, while TET2-mutant clones lack RTE-driven inflammation and instead enrich oxidative phosphorylation, ROS, and mTORC1 pathways.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1007/s11357-026-02510-6

build build 880 · 2bcef25 · 2026-11-18